Delisting Determination,The Nasdaq Stock Market, LLC,
July 17, 2009, Alseres Pharmaceuticals, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove from
listing the common stock of Alseres Pharmaceuticals, Inc.
(the Company), effective at the opening of the
trading session on July 27, 2009. Based on a review of
the information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for
listing on the Exchange pursuant to Listing Rule
5550(b). The Company was notified of the Staffs
determination on April 9, 2009. The Company
requested a review of the Staffs determination before the
Listing Qualifications Hearings Panel, but withdrew its
request for an appeal before the scheduled hearing
date.  On May 8, 2009, trading in the Companys
securities was suspended and the staffs delisting
determination became final.